INSTITUTO DE OFTALMOBIOLOGÍA APLICADA (IOBA)
Institut
Hospital General Universitario de Valencia
Valencia, EspañaPublicacions en col·laboració amb investigadors/es de Hospital General Universitario de Valencia (9)
2023
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
-
Safety, biocompatibility, and potential functionality of a new accommodative intraocular lens: An experimental study in rabbits
Heliyon, Vol. 9, Núm. 9
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014
-
EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations
Revista Iberoamericana de Micologia, Vol. 31, Núm. 3, pp. 157-175
2012
-
A propensity score matching application: Indications and results of adding scleral buckle to vitrectomy: The Retina 1 project: Report 3
European Journal of Ophthalmology, Vol. 22, Núm. 2, pp. 244-253
-
EComment. Organism functionality parameters in predicting the length of intensive care unit stays?
Interactive Cardiovascular and Thoracic Surgery